newsThe new €350 million biotechnology R&D centre is Boehringer Ingelheim’s…
25 April 2023 | By Catherine Eckford (European Pharmaceutical Review)
The new €350 million biotechnology R&D centre is Boehringer Ingelheim’s largest single investment in Germany to date.